These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2321980)

  • 21. Collateral sensitivity to thaliblastine and/or hyperthermia exhibited by a rat ovarian tumor cell line selected for resistance to cisplatin.
    Chen G; Zeller WJ; Todorov DK
    Anticancer Res; 1993; 13(5A):1269-75. PubMed ID: 8239496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual effect of erbB-2 depletion on the regulation of DNA repair and cell cycle mechanisms in non-small cell lung cancer cells.
    You XL; Yen L; Zeng-Rong N; Al Moustafa AE; Alaoui-Jamali MA
    Oncogene; 1998 Dec; 17(24):3177-86. PubMed ID: 9872333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
    Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells.
    Chen G; Zeller WJ
    Anticancer Res; 1994; 14(4A):1461-7. PubMed ID: 7979172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Synergistic effect of toremifene and cisplatin on human lung cancer cell line A549].
    Zhang X; Li Q; Han Y; Liu Z
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):537-9. PubMed ID: 12667319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin resistance and regulation of DNA repair in cAMP-dependent protein kinase mutants.
    Liu B; Cvijic ME; Jetzt A; Chin KV
    Cell Growth Differ; 1996 Aug; 7(8):1105-12. PubMed ID: 8853907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL; Poma EE; Kaufmann WK; Delmastro DA; Grady HL; Chaney SG
    Cancer Res; 1994 Jul; 54(13):3500-5. PubMed ID: 8012973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines.
    Johnson SW; Laub PB; Beesley JS; Ozols RF; Hamilton TC
    Cancer Res; 1997 Mar; 57(5):850-6. PubMed ID: 9041185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of DNA transcription- and repair-related genes in cisplatin-resistant human ovarian carcinoma cell line COC1/DDP].
    Cao MM; Zhang JR; Wang SM; Hu XG; Hu LJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1478-81. PubMed ID: 16354609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.
    Andrews PA; Howell SB
    Cancer Cells; 1990 Feb; 2(2):35-43. PubMed ID: 2204382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of resistance to cisplatin.
    Eastman A
    Cancer Treat Res; 1991; 57():233-49. PubMed ID: 1686719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.
    Calsou P; Salles B
    Cancer Chemother Pharmacol; 1993; 32(2):85-9. PubMed ID: 8485812
    [No Abstract]   [Full Text] [Related]  

  • 38. [A mechanism of cisplatin resistance in a cisplatin resistant lung cancer cell line].
    Bungo M; Nakagawa K; Saijo N
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):515-6. PubMed ID: 2321980
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination effect of caffeine and cisplatin on a cisplatin resistant human lung cancer cell line].
    Ohsaki Y; Ishida S; Fujikane T; Akiba Y; Osanai S; Onodera S
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1339-43. PubMed ID: 2369137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.